Advanced Search
Current and Breaking News for Professionals, Consumers and Media




FDA Approval Author: Staff Editor Last Updated: Sep 7, 2017 - 10:06:33 PM



FDA Warns of Potential Contamination in Multiple Brands of Drugs, Dietary Supplements

By Staff Editor
Aug 11, 2017 - 4:50:33 PM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page

(HealthNewsDigest.com) - SILVER SPRING, Md., Aug. 11, 2017 -- The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with the bacteria Burkholderia cepacia (B. cepacia) and the risk for severe patient infection.

The drug and dietary supplement products made by PharmaTech include liquid docusate sodium drugs (stool softeners), as well as various dietary supplements including liquid vitamin D drops and liquid multivitamins marketed for infants and children.

"B. cepacia poses a serious threat to vulnerable patients, including infants and young children who still have developing immune systems," said FDA Commissioner Scott Gottlieb, M.D. "These products were distributed nationwide to retailers, health care facilities, pharmacies and sold online – making it important that parents, patients and health care providers be made aware of the potential risk and immediately stop using these products."

According to the Centers for Disease Control and Prevention (CDC), B. cepacia poses the greatest threat to hospitalized patients, critically ill patients and people with health problems such as weakened immune systems and chronic lung diseases. The symptoms of B. cepacia infections vary widely from none at all to serious respiratory infections. It can spread from person-to-person by direct contact and is often resistant to common antibiotics.

Consumers, pharmacies and health care facilities should immediately stop using and dispensing all liquid drug and dietary supplement products manufactured by PharmaTech and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands. These distributors voluntarily recalled the following products:

LEADER BRAND

Liquid Multivitamin Supplement for Infants and Toddlers

50 mL

UPC: 096295128611

ALL LOTS

Liquid Vitamin D Supplement for Breastfed Infants 400 IU

50 mL

UPC: 096295128628

ALL LOTS

MAJOR PHARMACEUTICALS

Certa-Vite Liquid

236ML

00904-5023-09

ALL LOTS

Poly-Vita Drops

50ML

00904-5099-50

ALL LOTS

Poly-Vita Drops W/Iron

50ML

00904-5100-50

ALL LOTS

Ferrous Drops Iron Supplement

50ML

00904-6060-50

ALL LOTS

D-Vita Drops

50ML

00904-6273-50

ALL LOTS

Tri-Vita Drops

50ML

00904-6274-50

ALL LOTS

Senna Syrup

237ML

00904-6289-09

ALL LOTS

RUGBY LABORATORIES

C Liquid 500mg

118ML

00536-0160-97

ALL LOTS

Diocto Liquid 50mg/5ml

473ML

00536-0590-85

ALL LOTS

Ferrous Sulfate Elixir

473ML

00536-0650-85

ALL LOTS

Fer Iron Liquid 50ML

50ML

00536-0710-80

ALL LOTS

Senexon Liquid

237ML

00536-1000-59

ALL LOTS

Diocto Syrup 60MG/15ML

473ML

00536-1001-85

ALL LOTS

Aller Chlor Syrup

120ML

00536-1025-47

ALL LOTS

Calcionate Syrup

16OZ

00536-2770-85

ALL LOTS

Cerovite Liquid

236ML

00536-2790-59

ALL LOTS

D3 400iu Liquid

50ML

00536-8400-80

ALL LOTS

Poly-Vitamin Liquid

50ML

00536-8450-80

ALL LOTS

Tri-Vitamin Liquid

50ML

00536-8501-80

ALL LOTS

Poly-Vitamin W/Iron Liquid

50ML

00536-8530-80

ALL LOTS

On Aug. 8, 2017, the FDA advised health care professionals and patients not to use any liquid drug products manufactured by PharmaTech, following CDC's laboratory testing of PharmaTech's oral liquid docusate detected a strain of B. cepacia linked to recent patient infections.

In 2016, the FDA advised health care professionals and patients not to use liquid docusate drug products manufactured at PharmaTech's Davie, Florida, facility after the products were implicated in CDC's public health investigation into a multistate outbreak of B. cepacia infections.

The FDA encourages health care professionals and consumers to report adverse events or quality problems experienced with the use of drugs and dietary supplements products to the FDA's MedWatch Adverse Event Reporting program:

For more information:

Voluntary Nationwide Recall of all Liquid Products Manufactured by Pharmatech LLC and Distributed by Leader Brand, Major Pharmaceuticals, and Rugby Laboratories Due to Possible Product Contamination

FDA Updates on Multistate Outbreak of Burkholderia cepacia Infections

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Media Inquiries: Lyndsay Meyer, 240-402-5345, [email protected]
Consumer Inquiries: 888-INFO-FDA

View original content with multimedia:http://www.prnewswire.com/news-releases/fda-warns-of-potential-contamination-in-multiple-brands-of-drugs-dietary-supplements-300503420.html

SOURCE U.S. Food and Drug Administration

Web Site: http://www.fda.gov



Top of Page

HealthNewsDigest.com

FDA Approval
Latest Headlines


+ FDA Panel Recommends COVID-19 Booster Shots
+ FDA Approves 3D-printed Airway Stents Developed by Cleveland Clinic Doctor
+ Swallowable Device to Detect Pre-cancerous Barrett's Esophagus Receives FDA 510(k) Clearance
+ FDA Bans 7 Cancer-Causing Food Additives
+ Cost of Clinical Trials for New Drug FDA Approval Are Fraction of Total Tab
+ Memory Foam for Vascular Treatment Receives FDA Clearance
+ FDA Approved Non Surgical Balloon Weight Loss Method- patients Shed Up to 50 lbs
+ T2 Biosystems Receives FDA Clearance to Market T2Bacteria Panel for Detection of Sepsis-Causing Pathogens
+ FDA Warns About Illegal Use of Injectable Silicone for Body Contouring and Associated Health Risks
+ FDA Warns of Potential Contamination in Multiple Brands of Drugs, Dietary Supplements



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions